Minority Investigators Speak Out On The Value Of Affirmative Action

Recent political and judicial setbacks to affirmative action throughout the United States have minority and women scientists concerned that whatever advantages they have gained in the lab or clinic in the 30 years since such laws and regulations were enacted will be decimated. Impassioned national debate on the issue has been sparked by a number of widely publicized events. Among them are an effort by two professors in California to do away with any vestige of affirmative action in hiring by s

Written byRenee Twombly
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Impassioned national debate on the issue has been sparked by a number of widely publicized events. Among them are an effort by two professors in California to do away with any vestige of affirmative action in hiring by state agencies--including the state university system--and last month's Supreme Court decision to eliminate race as a factor in awarding scholarships.

But in the halls of academia, perhaps the most strident exchanges are taking place among the parties whom affirmative action programs were designed to benefit--minorities and women.

In some cases, argument centers on who in the research community has really been helped by affirmative action. Some African American scientists say that white women have been the primary recipients of affirmative action.

"Affirmative action doesn't work to bring the disadvantaged into the mainstream," contends James Wyche, an African American cell biologist at Brown University. "At many colleges, there has been little change over ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies